Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 5,480 | 3,586 | 4,111 | 11,202 | 9,265 |
| Cost of Goods | N/A | N/A | 2,334 | 10,775 | 9,119 |
| Gross Profit | 5,480 | 3,586 | 1,777 | 427 | 146 |
| Operating Expenses | 135,021 | 126,016 | 83,553 | 59,279 | 43,664 |
| Operating Income | -129,541 | -122,430 | -81,442 | -58,077 | -43,399 |
| Interest Expense | 0 | 0 | 927 | 1,576 | 1,796 |
| Other Income | 2,344 | 4,350 | 819 | 530 | 396 |
| Pre-tax Income | -127,197 | -118,080 | -81,550 | -59,123 | -44,799 |
| Net Income Continuous | -127,197 | -118,080 | -81,550 | -59,123 | -44,799 |
| Net Income | $-127,197 | $-118,080 | $-81,550 | $-59,123 | $-44,799 |
| EPS Basic Total Ops | -19.64 | -19.79 | -15.29 | -15.29 | -16.94 |
| EPS Basic Continuous Ops | -19.65 | -19.80 | -15.33 | -15.36 | -17.00 |
| EPS Diluted Total Ops | -19.64 | -19.79 | -15.29 | -15.29 | -16.94 |
| EPS Diluted Continuous Ops | -19.65 | -19.80 | -15.33 | -15.36 | -17.00 |
| EBITDA(a) | $-125,180 | $-118,934 | $-79,863 | $-55,600 | $-39,221 |